Layer, Chiang, et al. Genome Biology
Cancer Drug Shop BioVex Markets Legacy Technology for shRNA Delivery
The technology comprises replication-defective herpes simplex viruses that express shRNAs and can be delivered to the nervous system both in vitro and in vivo, and the company has been marketing it for research applications.
New to GenomeWeb? Register here quickly.